228 related articles for article (PubMed ID: 17805012)
1. Extensive hippocampal demyelination in multiple sclerosis.
Geurts JJ; Bö L; Roosendaal SD; Hazes T; Daniëls R; Barkhof F; Witter MP; Huitinga I; van der Valk P
J Neuropathol Exp Neurol; 2007 Sep; 66(9):819-27. PubMed ID: 17805012
[TBL] [Abstract][Full Text] [Related]
2. Regional hippocampal atrophy in multiple sclerosis.
Sicotte NL; Kern KC; Giesser BS; Arshanapalli A; Schultz A; Montag M; Wang H; Bookheimer SY
Brain; 2008 Apr; 131(Pt 4):1134-41. PubMed ID: 18375977
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of cortical lesions in MS: relation with cognitive impairment.
Roosendaal SD; Moraal B; Pouwels PJ; Vrenken H; Castelijns JA; Barkhof F; Geurts JJ
Mult Scler; 2009 Jun; 15(6):708-14. PubMed ID: 19435749
[TBL] [Abstract][Full Text] [Related]
4. Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains.
Zhang Z; Zhang ZY; Schittenhelm J; Wu Y; Meyermann R; Schluesener HJ
J Neuroimmunol; 2011 Aug; 237(1-2):73-9. PubMed ID: 21737148
[TBL] [Abstract][Full Text] [Related]
5. Remyelination can be extensive in multiple sclerosis despite a long disease course.
Patani R; Balaratnam M; Vora A; Reynolds R
Neuropathol Appl Neurobiol; 2007 Jun; 33(3):277-87. PubMed ID: 17442065
[TBL] [Abstract][Full Text] [Related]
6. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
Bergendal G; Fredrikson S; Almkvist O
Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
[TBL] [Abstract][Full Text] [Related]
7. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
Kutzelnigg A; Lucchinetti CF; Stadelmann C; Brück W; Rauschka H; Bergmann M; Schmidbauer M; Parisi JE; Lassmann H
Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
[TBL] [Abstract][Full Text] [Related]
8. Decreased hippocampal volume, indirectly measured, is associated with depressive symptoms and consolidation deficits in multiple sclerosis.
Kiy G; Lehmann P; Hahn HK; Eling P; Kastrup A; Hildebrandt H
Mult Scler; 2011 Sep; 17(9):1088-97. PubMed ID: 21546523
[TBL] [Abstract][Full Text] [Related]
9. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis and Alzheimer's disease.
Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
[TBL] [Abstract][Full Text] [Related]
11. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Norkute A; Hieble A; Braun A; Johann S; Clarner T; Baumgartner W; Beyer C; Kipp M
J Neurosci Res; 2009 May; 87(6):1343-55. PubMed ID: 19021291
[TBL] [Abstract][Full Text] [Related]
12. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions.
Werner K; Bitsch A; Bunkowski S; Hemmerlein B; Brück W
Glia; 2002 Oct; 40(1):121-9. PubMed ID: 12237849
[TBL] [Abstract][Full Text] [Related]
13. CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesions.
Trebst C; König F; Ransohoff R; Brück W; Stangel M
Mult Scler; 2008 Jul; 14(6):728-33. PubMed ID: 18611987
[TBL] [Abstract][Full Text] [Related]
14. Multislice brain myelin water fractions at 3T in multiple sclerosis.
Oh J; Han ET; Lee MC; Nelson SJ; Pelletier D
J Neuroimaging; 2007 Apr; 17(2):156-63. PubMed ID: 17441837
[TBL] [Abstract][Full Text] [Related]
15. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
[TBL] [Abstract][Full Text] [Related]
16. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion.
Barnett MH; Prineas JW
Ann Neurol; 2004 Apr; 55(4):458-68. PubMed ID: 15048884
[TBL] [Abstract][Full Text] [Related]
17. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
Wolswijk G; Balesar R
Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
[TBL] [Abstract][Full Text] [Related]
18. The role of edema and demyelination in chronic T1 black holes: a quantitative magnetization transfer study.
Levesque I; Sled JG; Narayanan S; Santos AC; Brass SD; Francis SJ; Arnold DL; Pike GB
J Magn Reson Imaging; 2005 Feb; 21(2):103-10. PubMed ID: 15666408
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment in three subtypes of multiple sclerosis.
Denney DR; Sworowski LA; Lynch SG
Arch Clin Neuropsychol; 2005 Dec; 20(8):967-81. PubMed ID: 15961271
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
Koning N; Bö L; Hoek RM; Huitinga I
Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
